We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMN Healthcare (AMN) to Report Q4 Earnings: What's in Store?
Read MoreHide Full Article
AMN Healthcare Services, Inc. (AMN - Free Report) is scheduled to release fourth-quarter 2021 results on Feb 17, after the closing bell. In the last reported quarter, the company delivered an earnings surprise of 29.1%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and matched once, the average surprise being 19.5%.
Q4 Estimates
Currently, the Zacks Consensus Estimate for fourth-quarter revenues is pegged at $1.28 billion, suggesting growth of 103.4% from the year-ago reported figure. The consensus mark for earnings stands at $2.58 per share, indicating a whopping rise of 158% from the prior-year quarter.
Factors to Note
Per the third-quarter 2021 earnings call, increased healthcare utilization and a tight labor market led to record high demand in several areas of the company’s business. This trend is likely to have continued in the fourth quarter as well.
In fact, the abovementioned factors aid AMN Healthcare’s collaborations and innovations, which are intended to provide greater access to patient care, thus instilling further confidence.
Per the preliminary announcement, fourth-quarter 2021 revenues are estimated between $1.35 billion and $1.36 billion. It is important to note here that this preliminary result outpaced previously issued (Nov 4, 2021) guidance, courtesy of solid demand throughout all revenue segments led by the Nurse and Allied segment and around $70 million more labor disruption revenues than included in the guidance.
AMN Healthcare Services Inc Price and EPS Surprise
AMN Healthcare’s strength in digital health capabilities with its AMN Passport and AMN Cares has been benefiting the company’s performance. The first one is the company’s mobile app for healthcare experts, while AMN Cares is a telehealth platform helping care teams to interface with employees or patients at home. The company expanded its scalable VMS solution, enabling a wide array of health care facilities to quickly staff and manage their entire range of contingent talent.
These developments are likely to have favored the company’s fourth-quarter results.
Per the preliminary announcement, management believes that healthcare labor shortages are widespread and expected to continue for a while, thereby demonstrating the requirement for short- and long-term workforce solutions and leading to wage inflation. These influences were stronger than anticipated in the fourth quarter.
What Our Quantitative Model Suggests
Per our proven model, a combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here as you will see.
Earnings ESP: AMN Healthcare has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company carries a Zacks Rank #2.
Stocks Worth a Look
Here are some medical stocks worth considering as these have the right combination of elements to post an earnings beat this quarter.
Allscripts Healthcare’s long-term earnings growth rate is estimated at 11.1%. The company’s earnings yield of 4.9% compares favorably with the industry’s (4.9%).
Viatris Inc. (VTRS - Free Report) has an Earnings ESP of +2.19% and a Zacks Rank of 3.
Viatris’ return on equity currently stands at 19.8% compared to the industry’s (2.06%). The company’s earnings yield of 24.6% compares favorably with the industry’s 0.7%.
DENTSPLY SIRONA Inc. (XRAY - Free Report) has an Earnings ESP of +2.97% and a Zacks Rank of 3.
DENTSPLY SIRONA’s long-term earnings growth rate is estimated at 22.2%. The company’s earnings yield of 5.9% compares favorably with the industry’s 4.5%.
Image: Bigstock
AMN Healthcare (AMN) to Report Q4 Earnings: What's in Store?
AMN Healthcare Services, Inc. (AMN - Free Report) is scheduled to release fourth-quarter 2021 results on Feb 17, after the closing bell. In the last reported quarter, the company delivered an earnings surprise of 29.1%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and matched once, the average surprise being 19.5%.
Q4 Estimates
Currently, the Zacks Consensus Estimate for fourth-quarter revenues is pegged at $1.28 billion, suggesting growth of 103.4% from the year-ago reported figure. The consensus mark for earnings stands at $2.58 per share, indicating a whopping rise of 158% from the prior-year quarter.
Factors to Note
Per the third-quarter 2021 earnings call, increased healthcare utilization and a tight labor market led to record high demand in several areas of the company’s business. This trend is likely to have continued in the fourth quarter as well.
In fact, the abovementioned factors aid AMN Healthcare’s collaborations and innovations, which are intended to provide greater access to patient care, thus instilling further confidence.
Per the preliminary announcement, fourth-quarter 2021 revenues are estimated between $1.35 billion and $1.36 billion. It is important to note here that this preliminary result outpaced previously issued (Nov 4, 2021) guidance, courtesy of solid demand throughout all revenue segments led by the Nurse and Allied segment and around $70 million more labor disruption revenues than included in the guidance.
AMN Healthcare Services Inc Price and EPS Surprise
AMN Healthcare Services Inc price-eps-surprise | AMN Healthcare Services Inc Quote
AMN Healthcare’s strength in digital health capabilities with its AMN Passport and AMN Cares has been benefiting the company’s performance. The first one is the company’s mobile app for healthcare experts, while AMN Cares is a telehealth platform helping care teams to interface with employees or patients at home. The company expanded its scalable VMS solution, enabling a wide array of health care facilities to quickly staff and manage their entire range of contingent talent.
These developments are likely to have favored the company’s fourth-quarter results.
Per the preliminary announcement, management believes that healthcare labor shortages are widespread and expected to continue for a while, thereby demonstrating the requirement for short- and long-term workforce solutions and leading to wage inflation. These influences were stronger than anticipated in the fourth quarter.
What Our Quantitative Model Suggests
Per our proven model, a combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here as you will see.
Earnings ESP: AMN Healthcare has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company carries a Zacks Rank #2.
Stocks Worth a Look
Here are some medical stocks worth considering as these have the right combination of elements to post an earnings beat this quarter.
Allscripts Healthcare Solutions, Inc. (MDRX - Free Report) has an Earnings ESP of +5.38% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Allscripts Healthcare’s long-term earnings growth rate is estimated at 11.1%. The company’s earnings yield of 4.9% compares favorably with the industry’s (4.9%).
Viatris Inc. (VTRS - Free Report) has an Earnings ESP of +2.19% and a Zacks Rank of 3.
Viatris’ return on equity currently stands at 19.8% compared to the industry’s (2.06%). The company’s earnings yield of 24.6% compares favorably with the industry’s 0.7%.
DENTSPLY SIRONA Inc. (XRAY - Free Report) has an Earnings ESP of +2.97% and a Zacks Rank of 3.
DENTSPLY SIRONA’s long-term earnings growth rate is estimated at 22.2%. The company’s earnings yield of 5.9% compares favorably with the industry’s 4.5%.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.